Use of Ethanol Lock Therapy to Reduce the Incidence of Catheter-Related Bloodstream Infections in Home Parenteral Nutrition Patients

Abstract

Background: Catheter-related bloodstream infection (CRBSI) is a serious complication for home parenteral nutrition (HPN) patients. To reduce the incidence of infection in frequently infected HPN patients, prophylactic ethanol lock therapy (ELT) was initiated. Methods: Nine patients were selected as candidates for ELT because of their history of recurrent CRBSI. Diagnosis of CRBSI was determined by symptoms correlating with positive peripheral and access device blood cultures. Medical-grade ethyl alcohol 25%–70% was instilled into the central venous access device and allowed to dwell for 2–4 hours. The incidence of CRBSI and catheter changes was compared before and after initiation of ELT. Results: Nine patients experienced 81 CRBSIs (8.3 per 1000 catheter-days) before starting ELT vs 9 infections (2.7 per 1000 catheter-days: relative risk [RR], 0.325; confidence interval [CI] 95%, 0.17–0.64) after ELT. Catheter changes were also reduced from 69 (7.0 per 1000 days) before ELT to 1 (0.3 per 1000 days: RR, 0.043; CI 95%, 0.01–0.25) after ELT. No significant adverse effects were noted, although some patients complained of transient dizziness and nausea. Conclusions: ELT shows promise in reducing the incidence of CRBSI in the frequently infected HPN population. Further studies are warranted.

Ethyl alcohol 25%–70% was used as a prophylactic lock therapy in frequently infected home parenteral nutrition patients. Results suggest that this therapy is effective in reducing the incidence of catheter-related bloodstream infection and catheter changes. No adverse effects were noted.

Get full access to this article

View all access options for this article.

References

Ryder M. Evidence-based practice in the management of vascular access devices for home parenteral nutrition therapy. JPEN J Parenter Enteral Nutr 2006;30(1 suppl): S82–S93.

Maki DG, Kluger DM, Crnich DJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proc. 2006 ;81:1159– 1171.

Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection, II: long-term devices. Clin Infect Dis. 2002 ;34:1232– 1242.

Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002 ;15:167– 193.

Messing B, Peitra-Cohen S, Debure A, Bernier J. Antiobiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988;12:185– 189.

Megarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a review of the literature. Ann Pharmacother. 2005 ;39:311– 317.

Bestul MB, VandenBussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy. 2005 ;25:211– 227.

O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002 ;51(RR-10):1– 29.

Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother. 2006;50:1865– 1868.

10.

Percival SL, Kite P, Eastwood K, et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol. 2005;26:515– 519.

11.

Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis. 2003 ;36:1539– 1544.

12.

Kite P, Eastwood K, Sugden S, Percival SL. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol. 2004;42:3073– 3076.

13.

Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect. 2004 ;49:20– 22.

14.

Johnston DA, Walker K, Richards J, Pennington CR. Ethanol flush for the prevention of catheter occlusion. Clin Nutr. 1992 ;11:97– 100.

15.

Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005;26:708– 714.

16.

Bell AL, Jayaraman R, Vercaigne LM. Effect of ethanol/trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters. Clin Nephrol. 2006 ;65:342– 348.

17.

Ball PA, Brokenshire E, Parry B, et al. Ethanol locking as a possible treatment for microbial contamination of long-term central venous catheters [letter]. Nutrition. 2003 ;19:570 .

18.

Maki DG, Crnich CJ, Safdar N. Successful use of a 25% alcohol lock solution for prevention of recurrent CVC-related blood-stream infection in a patient on home TNA. Abstract presented at: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy;September 27–30, 2002; Washington, DC.

19.

Dannenberg C, Bierback U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with Broviac catheter. J Pediatr Hematol Oncol. 2003 ;25:616– 621.

20.

Opilla MT, Wolff-Small T, Marra AR, Kirby DF, Edmond MB. Use of ethanol lock therapy to prevent catheter related blood stream infection in frequently infected home total parenteral nutrition patients [abstract].Nutr Clin Pract. 2006;21:194– 195. Abstract NP02.